Analyze Diet
Journal of virology1989; 63(6); 2492-2496; doi: 10.1128/JVI.63.6.2492-2496.1989

Change in host cell tropism associated with in vitro replication of equine infectious anemia virus.

Abstract: Similar to other human and animal lentiviruses, equine infectious anemia virus (EIAV) is detectable in vivo in cells of the monocyte-macrophage lineage. Owing to their short-lived nature, horse peripheral blood macrophage cultures (HMC) are rarely used for in vitro propagation of EIAV, and equine dermal (ED) or kidney cell cultures, which can be repeatedly passed in vitro, are used in most studies. However, wild-type isolates of EIAV will not grow in these cell types without extensive adaptation, a process which may attenuate viral virulence. To better define the effect of host cell tropism on the virulence and pathogenesis of EIAV, we studied a field isolate of EIAV during in vitro adaptation to growth in an ED cell line. Interestingly, as the virus adapted to growth in ED cells, there was a corresponding decrease in infectivity for HMC, and the final ED-adapted isolate was more than 100-fold more infectious for ED cells than for HMC. In vivo studies indicated that the ED-adapted isolate was able to replicate in experimentally infected horses, although no clinical signs of EIA were observed. Thus, selection for in vitro replication on ED cells correlated with a loss of EIAV tropism for HMC in vitro and was associated with avirulence in vivo.
Publication Date: 1989-06-01 PubMed ID: 2470916PubMed Central: PMC250709DOI: 10.1128/JVI.63.6.2492-2496.1989Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research focuses on how equine infectious ania virus (EIAV) adapts to growth inside equine dermal cells in culture, and how this adaptation affects its virulence and infectivity in both host cells and live horses.

Overview of Equine Infectious Anemia Virus (EIAV)

  • EIAV is a lentivirus similar to those found in humans and other animals, mainly affecting cells from the monocyte-macrophage lineage.
  • Due to the short-lived nature of horse peripheral blood macrophage cultures (HMC), equine dermal (ED) or kidney cell cultures are usually used in studies for EIAV.
  • It’s crucial to note that wild-type instances of EIAV don’t grow in these cell types without undergoing significant adaptation, which may reduce the virus’s virulence.

Study of EIAV Adaptation in ED Cells

  • The study focused on a field isolate of EIAV and examined its adaptation in vitro to grow in an ED cell line.
  • As the virus adapted to the ED cells, there was a corresponding decrease in infectivity for HMC.
  • Once the virus completed its adaptation to the ED cells, it was over 100 times more infectious for the ED cells than the HMC.

In Vivo Impact of the ED-Adapted Virus

  • When the fully ED-adapted EIAV was introduced into horses in a controlled experiment, it was able to replicate but did not cause any noticeable clinical signs of EIA to appear in the horses.
  • This suggests that the adaptation for growing in ED cells, which correlates with a loss of tropism for HMC in vitro, may also be associated with avirulence (non-disease causing) in vivo.

Implications of the Findings

  • These results could be an important insight into how viruses adapt to various hosts, and how such adaptation influences the virulence of the virus.
  • This could lead to new understandings or approaches for disease prevention and control in horses and potentially other animals affected by similar lentiviruses.

Cite This Article

APA
Carpenter S, Chesebro B. (1989). Change in host cell tropism associated with in vitro replication of equine infectious anemia virus. J Virol, 63(6), 2492-2496. https://doi.org/10.1128/JVI.63.6.2492-2496.1989

Publication

ISSN: 0022-538X
NlmUniqueID: 0113724
Country: United States
Language: English
Volume: 63
Issue: 6
Pages: 2492-2496

Researcher Affiliations

Carpenter, S
  • Laboratory of Persistent Viral Diseases, National Institute of Allergy and Infectious Diseases, Hamilton, Montana 59840.
Chesebro, B

    MeSH Terms

    • Animals
    • Cell Line
    • Cells, Cultured
    • Cytopathogenic Effect, Viral
    • Fluorescent Antibody Technique
    • Horses
    • Immunodiffusion
    • Infectious Anemia Virus, Equine / physiology
    • Macrophages / microbiology
    • RNA-Directed DNA Polymerase
    • Virus Replication

    References

    This article includes 36 references
    1. Kobayashi K, Kono Y. Propagation and titration of equine infectious anemia virus in horse leukocyte culture.. Natl Inst Anim Health Q (Tokyo) 1967 Spring;7(1):8-20.
      pubmed: 4293214
    2. STEIN CD, MOTT LO, GATES DW. Some observations on carriers of equine infectious anemia.. J Am Vet Med Assoc 1955 Apr;126(937):277-86.
      pubmed: 14353779
    3. Coggins L, Norcross NL. Immunodiffusion reaction in equine infectious anemia.. Cornell Vet 1970 Apr;60(2):330-5.
      pubmed: 4986043
    4. Kono Y, Kobayashi K. Changes in pathogenicity of equine infectious anemia virus during passages in horse leukocyte cultures.. Natl Inst Anim Health Q (Tokyo) 1970 Fall;10(3):106-12.
      pubmed: 4320651
    5. McGuire TC, Crawford TB, Henson JB. Immunofluorescent localization of equine infectious anemia virus in tissue.. Am J Pathol 1971 Feb;62(2):283-94.
      pubmed: 4322275
    6. Malmquist WA, Barnett D, Becvar CS. Production of equine infectious anemia antigen in a persistently infected cell line.. Arch Gesamte Virusforsch 1973;42(4):361-70.
      pubmed: 4358259doi: 10.1007/BF01250717google scholar: lookup
    7. Charman HP, Bladen S, Gilden RV, Coggins L. Equine infectious anemia virus: evidence favoring classification as a retravirus.. J Virol 1976 Sep;19(3):1073-9.
      pubmed: 61283doi: 10.1128/JVI.19.3.1073-1079.1976google scholar: lookup
    8. Gutekunst DE, Becvar CS. Responses in horses infected with equine infectious anemia virus adapted to tissue culture.. Am J Vet Res 1979 Jul;40(7):974-7.
      pubmed: 228570
    9. Parekh B, Issel CJ, Montelaro RC. Equine infectious anemia virus, a putative lentivirus, contains polypeptides analogous to prototype-C oncornaviruses.. Virology 1980 Dec;107(2):520-5.
      pubmed: 6256947doi: 10.1016/0042-6822(80)90319-0google scholar: lookup
    10. Goff S, Traktman P, Baltimore D. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.. J Virol 1981 Apr;38(1):239-48.
      pubmed: 6165830doi: 10.1128/JVI.38.1.239-248.1981google scholar: lookup
    11. Narayan O, Wolinsky JS, Clements JE, Strandberg JD, Griffin DE, Cork LC. Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats.. J Gen Virol 1982 Apr;59(Pt 2):345-56.
      pubmed: 6281373doi: 10.1099/0022-1317-59-2-345google scholar: lookup
    12. Benton CV, Brown BL, Harshman JS, Gilden RV. In vitro host range of equine infectious anemia virus.. Intervirology 1981;16(4):225-32.
      pubmed: 6177659doi: 10.1159/000149271google scholar: lookup
    13. Montelaro RC, Lohrey N, Parekh B, Blakeney EW, Issel CJ. Isolation and comparative biochemical properties of the major internal polypeptides of equine infectious anemia virus.. J Virol 1982 Jun;42(3):1029-38.
    14. Orrego A, Issel CJ, Montelaro RC, Adams WV Jr. Virulence and in vitro growth of a cell-adapted strain of equine infectious anemia virus after serial passage in ponies.. Am J Vet Res 1982 Sep;43(9):1556-60.
      pubmed: 6293349
    15. Narayan O, Kennedy-Stoskopf S, Sheffer D, Griffin DE, Clements JE. Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages.. Infect Immun 1983 Jul;41(1):67-73.
      pubmed: 6862634doi: 10.1128/iai.41.1.67-73.1983google scholar: lookup
    16. Evans KS, Carpenter SL, Sevoian M. Detection of equine infectious anemia virus in horse leukocyte cultures derived from horses in various stages of equine infectious anemia viral infection.. Am J Vet Res 1984 Jan;45(1):20-5.
      pubmed: 6322623
    17. Chesebro B, Wehrly K, Nishio J, Evans L. Leukemia induction by a new strain of Friend mink cell focus-inducing virus: synergistic effect of Friend ecotropic murine leukemia virus.. J Virol 1984 Jul;51(1):63-70.
      pubmed: 6202886doi: 10.1128/JVI.51.1.63-70.1984google scholar: lookup
    18. Montelaro RC, Parekh B, Orrego A, Issel CJ. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.. J Biol Chem 1984 Aug 25;259(16):10539-44.
      pubmed: 6206055
    19. Sitbon M, Nishio J, Wehrly K, Chesebro B. Pseudotyping of dual-tropic recombinant viruses generated by infection of mice with different ecotropic murine leukemia viruses.. Virology 1985 Jan 15;140(1):144-51.
      pubmed: 2981449doi: 10.1016/0042-6822(85)90453-2google scholar: lookup
    20. Sitbon M, Nishio J, Wehrly K, Lodmell D, Chesebro B. Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses.. Virology 1985 Feb;141(1):110-8.
      pubmed: 2983493doi: 10.1016/0042-6822(85)90187-4google scholar: lookup
    21. Chiu IM, Yaniv A, Dahlberg JE, Gazit A, Skuntz SF, Tronick SR, Aaronson SA. Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses.. Nature 1985 Sep 26-Oct 2;317(6035):366-8.
      pubmed: 2995822doi: 10.1038/317366a0google scholar: lookup
    22. Stephens RM, Casey JW, Rice NR. Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus.. Science 1986 Feb 7;231(4738):589-94.
      pubmed: 3003905doi: 10.1126/science.3003905google scholar: lookup
    23. Gonda MA, Braun MJ, Clements JE, Pyper JM, Wong-Staal F, Gallo RC, Gilden RV. Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses.. Proc Natl Acad Sci U S A 1986 Jun;83(11):4007-11.
      pubmed: 2424014doi: 10.1073/pnas.83.11.4007google scholar: lookup
    24. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection.. Science 1986 Jul 11;233(4760):215-9.
      pubmed: 3014648doi: 10.1126/science.3014648google scholar: lookup
    25. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients.. Proc Natl Acad Sci U S A 1986 Sep;83(18):7089-93.
      pubmed: 3018755doi: 10.1073/pnas.83.18.7089google scholar: lookup
    26. Yaniv A, Dahlberg J, Gazit A, Sherman L, Chiu IM, Tronick SR, Aaronson SA. Molecular cloning and physical characterization of integrated equine infectious anemia virus: molecular and immunologic evidence of its close relationship to ovine and caprine lentiviruses.. Virology 1986 Oct 15;154(1):1-8.
      pubmed: 3750842doi: 10.1016/0042-6822(86)90424-1google scholar: lookup
    27. Rushlow K, Olsen K, Stiegler G, Payne SL, Montelaro RC, Issel CJ. Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus.. Virology 1986 Dec;155(2):309-21.
      pubmed: 2431539doi: 10.1016/0042-6822(86)90195-9google scholar: lookup
    28. Henderson LE, Sowder RC, Smythers GW, Oroszlan S. Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins.. J Virol 1987 Apr;61(4):1116-24.
    29. Kawakami T, Sherman L, Dahlberg J, Gazit A, Yaniv A, Tronick SR, Aaronson SA. Nucleotide sequence analysis of equine infectious anemia virus proviral DNA.. Virology 1987 Jun;158(2):300-12.
      pubmed: 3035786doi: 10.1016/0042-6822(87)90202-9google scholar: lookup
    30. Carpenter S, Evans LH, Sevoian M, Chesebro B. Role of the host immune response in selection of equine infectious anemia virus variants.. J Virol 1987 Dec;61(12):3783-9.
    31. Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, Martin MA. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.. J Virol 1988 Jan;62(1):139-47.
      pubmed: 3257102doi: 10.1128/JVI.62.1.139-147.1988google scholar: lookup
    32. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.. Science 1988 Feb 5;239(4840):617-22.
      pubmed: 3277274doi: 10.1126/science.3277274google scholar: lookup
    33. Montelaro RC, Robey WG, West MD, Issel CJ, Fischinger PJ. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus.. J Gen Virol 1988 Jul;69 ( Pt 7):1711-7.
      pubmed: 2839603doi: 10.1099/0022-1317-69-7-1711google scholar: lookup
    34. Fisher AG, Ensoli B, Looney D, Rose A, Gallo RC, Saag MS, Shaw GM, Hahn BH, Wong-Staal F. Biologically diverse molecular variants within a single HIV-1 isolate.. Nature 1988 Aug 4;334(6181):444-7.
      pubmed: 2841608doi: 10.1038/334444a0google scholar: lookup
    35. Chesebro B, Wehrly K. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity.. J Virol 1988 Oct;62(10):3779-88.
    36. Kono Y, Yokomizo Y. Attempts to cultivate the equine infectious anemia virus in various types of cells.. Natl Inst Anim Health Q (Tokyo) 1968 Winter;8(4):182-6.
      pubmed: 4307837

    Citations

    This article has been cited 27 times.
    1. Wang XF, Liu Q, Wang YH, Wang S, Chen J, Lin YZ, Ma J, Zhou JH, Wang X. Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies In Vitro and In Vivo. J Virol 2018 Apr 15;92(8).
      doi: 10.1128/JVI.02150-17pubmed: 29386282google scholar: lookup
    2. Brindley MA, Widrlechner MP, McCoy JA, Murphy P, Hauck C, Rizshsky L, Nikolau B, Maury W. Inhibition of lentivirus replication by aqueous extracts of Prunella vulgaris. Virol J 2009 Jan 20;6:8.
      doi: 10.1186/1743-422X-6-8pubmed: 19154592google scholar: lookup
    3. Brindley MA, Zhang B, Montelaro RC, Maury W. An equine infectious anemia virus variant superinfects cells through novel receptor interactions. J Virol 2008 Oct;82(19):9425-32.
      doi: 10.1128/JVI.01142-08pubmed: 18667522google scholar: lookup
    4. Brindley MA, Maury W. Equine infectious anemia virus entry occurs through clathrin-mediated endocytosis. J Virol 2008 Feb;82(4):1628-37.
      doi: 10.1128/JVI.01754-07pubmed: 18057237google scholar: lookup
    5. Lee JH, Murphy SC, Belshan M, Sparks WO, Wannemuehler Y, Liu S, Hope TJ, Dobbs D, Carpenter S. Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain. J Virol 2006 Apr;80(8):3844-52.
    6. Brindley MA, Maury W. Endocytosis and a low-pH step are required for productive entry of equine infectious anemia virus. J Virol 2005 Dec;79(23):14482-8.
    7. Maury W, Thompson RJ, Jones Q, Bradley S, Denke T, Baccam P, Smazik M, Oaks JL. Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism. J Virol 2005 May;79(9):5653-64.
    8. Baccam P, Thompson RJ, Li Y, Sparks WO, Belshan M, Dorman KS, Wannemuehler Y, Oaks JL, Cornette JL, Carpenter S. Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype. J Virol 2003 Nov;77(22):12122-31.
    9. Maury W, Wright PJ, Bradley S. Characterization of a cytolytic strain of equine infectious anemia virus. J Virol 2003 Feb;77(4):2385-99.
    10. Maury W, Oaks JL, Bradley S. Equine endothelial cells support productive infection of equine infectious anemia virus. J Virol 1998 Nov;72(11):9291-7.
    11. Belshan M, Harris ME, Shoemaker AE, Hope TJ, Carpenter S. Biological characterization of Rev variation in equine infectious anemia virus. J Virol 1998 May;72(5):4421-6.
    12. Cook RF, Leroux C, Cook SJ, Berger SL, Lichtenstein DL, Ghabrial NN, Montelaro RC, Issel CJ. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. J Virol 1998 Feb;72(2):1383-93.
    13. Payne SL, Qi XM, Shao H, Dwyer A, Fuller FJ. Disease induction by virus derived from molecular clones of equine infectious anemia virus. J Virol 1998 Jan;72(1):483-7.
      doi: 10.1128/JVI.72.1.483-487.1998pubmed: 9420249google scholar: lookup
    14. Maury W, Perryman S, Oaks JL, Seid BK, Crawford T, McGuire T, Carpenter S. Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus. J Virol 1997 Jul;71(7):4929-37.
    15. Beisel CE, Edwards JF, Dunn LL, Rice NR. Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein. J Virol 1993 Feb;67(2):832-42.
      doi: 10.1128/JVI.67.2.832-842.1993pubmed: 8419648google scholar: lookup
    16. Suarez DL, VanDerMaaten MJ, Wood C, Whetstone CA. Isolation and characterization of new wild-type isolates of bovine lentivirus. J Virol 1993 Aug;67(8):5051-5.
    17. Carpenter S, Nadin-Davis SA, Wannemuehler Y, Roth JA. Identification of transactivation-response sequences in the long terminal repeat of bovine immunodeficiency-like virus. J Virol 1993 Jul;67(7):4399-403.
    18. Kim CH, Casey JW. In vivo replicative status and envelope heterogeneity of equine infectious anemia virus in an inapparent carrier. J Virol 1994 Apr;68(4):2777-80.
    19. Maury W. Monocyte maturation controls expression of equine infectious anemia virus. J Virol 1994 Oct;68(10):6270-9.
    20. Sellon DC, Fuller FJ, McGuire TC. The immunopathogenesis of equine infectious anemia virus. Virus Res 1994 May;32(2):111-38.
      doi: 10.1016/0168-1702(94)90038-8pubmed: 8067050google scholar: lookup
    21. McNearney T, Westervelt P, Thielan BJ, Trowbridge DB, Garcia J, Whittier R, Ratner L. Limited sequence heterogeneity among biologically distinct human immunodeficiency virus type 1 isolates from individuals involved in a clustered infectious outbreak. Proc Natl Acad Sci U S A 1990 Mar;87(5):1917-21.
      doi: 10.1073/pnas.87.5.1917pubmed: 2308953google scholar: lookup
    22. Whetter L, Archambault D, Perry S, Gazit A, Coggins L, Yaniv A, Clabough D, Dahlberg J, Fuller F, Tronick S. Equine infectious anemia virus derived from a molecular clone persistently infects horses. J Virol 1990 Dec;64(12):5750-6.
    23. Waldman WJ, Roberts WH, Davis DH, Williams MV, Sedmak DD, Stephens RE. Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells. Arch Virol 1991;117(3-4):143-64.
      doi: 10.1007/BF01310761pubmed: 1850227google scholar: lookup
    24. Carpenter S, Alexandersen S, Long MJ, Perryman S, Chesebro B. Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus. J Virol 1991 Mar;65(3):1605-10.
    25. Alexandersen S, Carpenter S. Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus. J Virol 1991 Aug;65(8):4255-62.
    26. Perry ST, Flaherty MT, Kelley MJ, Clabough DL, Tronick SR, Coggins L, Whetter L, Lengel CR, Fuller F. The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro. J Virol 1992 Jul;66(7):4085-97.
    27. Carpenter S, Miller LD, Alexandersen S, Whetstone CA, VanDerMaaten MJ, Viuff B, Wannemuehler Y, Miller JM, Roth JA. Characterization of early pathogenic effects after experimental infection of calves with bovine immunodeficiency-like virus. J Virol 1992 Feb;66(2):1074-83.